Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 2 |
Apple
AAPL
|
+$931M |
| 3 |
Tesla
TSLA
|
+$793M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$769M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$644M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$703M |
| 2 |
Bank of America
BAC
|
+$690M |
| 3 |
Amazon
AMZN
|
+$678M |
| 4 |
JPMorgan Chase
JPM
|
+$601M |
| 5 |
Meta Platforms (Facebook)
META
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.11% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.48% |
| 4 | Healthcare | 0.92% |
| 5 | Communication Services | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTP
9651
PUT
DELISTED
Nam Tai Property Inc.
NTP
| $242K | ﹤0.01% |
41,400
+29,800
| +257% | +$159K |
|
9652
Artivion
AORT
$1.31B
| $241K | ﹤0.01% |
10,225
-30,083
| -75% | -$610K |
|
9653
PUT
Banc of California
BANC
$2.95B
| $241K | ﹤0.01% |
16,400
-4,900
| -23% | -$64K |
|
9654
PUT
Electromed
ELMD
$248M
| $241K | ﹤0.01% |
+24,600
| New | +$232K |
|
9655
Enova International
ENVA
$5.79B
| $241K | ﹤0.01% |
+9,739
| New | +$199K |
|
9656
Greif
GEF
$4.78B
| $241K | ﹤0.01% |
+5,141
| New | +$233K |
|
9657
State Street SPDR S&P Global Natural Resources ETF
GNR
$5.12B
| $241K | ﹤0.01% |
5,371
-96,068
| -95% | -$3.97M |
|
|
UMH
9658
UMH Properties
UMH
$1.41B
| $241K | ﹤0.01% |
+16,267
| New | +$236K |
|
9659
PUT
UroGen Pharma
URGN
$2.13B
| $241K | ﹤0.01% |
13,400
-18,600
| -58% | -$390K |
|
9660
PUT
Vera Bradley
VRA
$94.1M
| $241K | ﹤0.01% |
30,300
-21,300
| -41% | -$161K |
|
9661
Global X FTSE Southeast Asia ETF
ASEA
$103M
| $240K | ﹤0.01% |
+16,597
| New | +$222K |
|
9662
Invesco Zacks Mid-Cap ETF
CZA
$184M
| $240K | ﹤0.01% |
3,159
-27,317
| -90% | -$1.98M |
|
9663
iShares 7-10 Year Treasury Bond ETF
IEF
$42.9B
| $240K | ﹤0.01% |
+2,000
| New | +$241K |
|
|
IGMS
9664
DELISTED
IGM Biosciences
IGMS
| $240K | ﹤0.01% |
2,720
-4,559
| -63% | -$320K |
|
9665
Lineage Cell Therapeutics
LCTX
$281M
| $240K | ﹤0.01% |
+136,343
| New | +$191K |
|
9666
CALL
Limoneira
LMNR
$250M
| $240K | ﹤0.01% |
+14,400
| New | +$216K |
|
9667
State Street SPDR S&P Kensho Intelligent Structures ETF
SIMS
$8.24M
| $240K | ﹤0.01% |
5,695
-7,961
| -58% | -$296K |
|
|
INOV
9668
PUT
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $240K | ﹤0.01% |
13,200
-5,000
| -27% | -$107K |
|
|
LDL
9669
DELISTED
Lydall, Inc.
LDL
| $240K | ﹤0.01% |
+7,999
| New | +$193K |
|
9670
PUT
Ardmore Shipping
ASC
$709M
| $239K | ﹤0.01% |
73,000
+13,100
| +22% | +$41.8K |
|
9671
CALL
InflaRx
IFRX
$329M
| $239K | ﹤0.01% |
47,600
-12,000
| -20% | -$54K |
|
9672
Newmark Group
NMRK
$2.87B
| $239K | ﹤0.01% |
32,808
-41,505
| -56% | -$257K |
|
9673
PUT
Pebblebrook Hotel Trust
PEB
$2.09B
| $239K | ﹤0.01% |
12,700
+2,500
| +25% | +$40.5K |
|
9674
PUT
Stepan Co
SCL
$1.42B
| $239K | ﹤0.01% |
+2,000
| New | +$235K |
|
|
OSH
9675
PUT
DELISTED
Oak Street Health, Inc.
OSH
| $239K | ﹤0.01% |
+3,900
| New | +$205K |
|
Similar funds
Jeff Yass's Q4 2020 Portfolio in Review
As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
- Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
- Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
- Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
- Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
- Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.